CAMICIOTTOLI, GIANNA
 Distribuzione geografica
Continente #
NA - Nord America 7.550
EU - Europa 5.997
AS - Asia 3.996
SA - Sud America 401
AF - Africa 117
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.163
Nazione #
US - Stati Uniti d'America 7.460
RU - Federazione Russa 1.851
IT - Italia 1.617
SG - Singapore 1.096
CN - Cina 905
PL - Polonia 753
HK - Hong Kong 607
IE - Irlanda 504
VN - Vietnam 463
SE - Svezia 418
KR - Corea 348
BR - Brasile 324
FI - Finlandia 209
FR - Francia 177
DE - Germania 168
JO - Giordania 140
IN - India 108
GB - Regno Unito 95
AU - Australia 94
JP - Giappone 90
UA - Ucraina 79
BD - Bangladesh 65
CA - Canada 48
CI - Costa d'Avorio 41
ID - Indonesia 37
TR - Turchia 32
CH - Svizzera 27
AR - Argentina 26
IQ - Iraq 25
MX - Messico 23
NG - Nigeria 21
NL - Olanda 21
BE - Belgio 17
PK - Pakistan 14
EC - Ecuador 13
RO - Romania 13
ZA - Sudafrica 13
CL - Cile 10
PH - Filippine 10
AE - Emirati Arabi Uniti 8
ES - Italia 8
UZ - Uzbekistan 8
VE - Venezuela 8
KE - Kenya 7
MA - Marocco 7
CO - Colombia 6
EG - Egitto 6
PY - Paraguay 6
SA - Arabia Saudita 6
AL - Albania 5
BJ - Benin 5
EU - Europa 5
PE - Perù 5
RS - Serbia 5
SI - Slovenia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
LT - Lituania 4
MY - Malesia 4
TH - Thailandia 4
BG - Bulgaria 3
KW - Kuwait 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AT - Austria 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LV - Lettonia 2
SC - Seychelles 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KI - Kiribati 1
Totale 18.155
Città #
Santa Clara 1.865
Warsaw 748
Singapore 745
Ashburn 578
Dublin 504
Hong Kong 484
Chandler 478
Fairfield 470
Milan 380
San Jose 377
Seoul 344
Beijing 220
Woodbridge 199
The Dalles 186
Cambridge 177
Seattle 164
Wilmington 159
Houston 150
Hefei 149
Buffalo 142
Rome 142
Hanoi 138
Ho Chi Minh City 134
Princeton 133
Jacksonville 131
Florence 124
Lauterbourg 124
Ann Arbor 115
Los Angeles 113
Melbourne 91
Tokyo 87
Moscow 85
Boston 82
Medford 78
Boardman 76
New York 72
Helsinki 71
Lawrence 63
Altamura 57
Mumbai 57
Munich 50
Kent 47
Shanghai 45
Council Bluffs 44
Abidjan 41
Dallas 35
Redondo Beach 35
Norwalk 34
San Diego 34
Haiphong 27
Turin 26
Naples 25
Falls Church 24
Bern 23
Jakarta 23
São Paulo 23
Frankfurt am Main 22
Orem 22
Hillsboro 21
Figino 20
Yubileyny 19
Abuja 18
Da Nang 18
Bologna 17
Izmir 17
London 17
Turku 17
Brussels 16
Chicago 16
Toronto 16
Chennai 15
Clifton 15
Palermo 15
Brooklyn 14
Dong Ket 14
Paris 14
Atlanta 13
Bari 13
Guangzhou 12
San Francisco 12
Bengaluru 11
Genoa 11
Baghdad 10
Messina 10
Vicenza 10
West Jordan 10
Andover 9
Miano 9
Mountain View 9
Reggio Emilia 9
Stockholm 9
Amsterdam 8
Catania 8
Dearborn 8
Johannesburg 8
Padua 8
Phoenix 8
Redwood City 8
Rio de Janeiro 8
Tianjin 8
Totale 11.600
Nome #
COPD: maximization of bronchodilation 389
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD 326
Is intrathoracic tracheal collapsibility correlated to clinical phenotypes and sex in patients with COPD? 323
Immunoglobulin replacement therapy for yellow nail syndrome 307
Interstitial lung disease in systemic sclerosis: Where do we stand? 283
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease 268
Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. 254
Non-contact detection of breathing using a microwave sensor 248
Discussione di casi clinici: Il caso di Pneumologia 231
Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes. 216
Chronic Obstructive Pulmonary Disease: Pulmonary Function and CT Lung Attenuation Do Not Show Linear Correlation. Paoletti M, Cestelli L, 215
CHANGES IN TRANSCUTANEOUS OXYGEN PARTIAL PRESSURE AS AN INDEX OF RESPONSE TO INHALED METHACHOLINE IN ASTHMATIC PATIENTS. 210
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. 206
Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. 200
BODE_index, modified BODE-index and ADO score in Chronic Obstructive Pulmonary Disease: relationship with COPD phenotypes and CT lung density changes 198
Different respiratory behaviors disclosed by induced bronchoconstriction in mild asthma patients. 197
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 192
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. 190
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 190
Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease 188
Glottis Closure Influences Tracheal Size Changes in Inspiratory and Expiratory CT in Patients with COPD. 184
Whole-lung volume and density in spirometrically-gated inspiratory and expiratory CT in systemic sclerosis: correlation with static volumes at pulmonary function tests 181
Induced sputum in systemic sclerosis interstitial lung disease: Comparison to healthy controls and bronchoalveolar lavage 173
Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report 169
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 169
ENFISEMA POLMONARE 167
A prospective study on respiratory function in children affected with Systemic Lupus Erithematosus 166
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 164
Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial 161
Agreement between two methods fr assessing bioequivalence of inhaled salbutamol. 159
Airway response to fenoterol hydrobromide and oxitropium bromide alone or in sequence in stable COPD patients 159
Comparison of spirometric-gated and -ungated HRCT in COPD. 157
Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer 154
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life 152
Fog-induced respiratory responses are attenuated by nedocromil sodium in humans 152
Classification of COPD patients by using a standardised diagnostic questionnaire 152
Thin-section and low-dose volumetric computed tomographic densitometry of the lung in systemic sclerosis. 150
Low agreement of visual rating for detailed quantification of pulmonary emphysema in whole lung CT 150
Studio prospettico della funzione respiratoria in bambini affetti da Lupus Eritematoso Sistemico 146
Chronic effort dyspnea explained by lung function tests and by HRCT and CRX radiografic patterns in COPD: a post-hoc analysis in 51 patients 145
Clinical Identification of CT-Determined COPD Phenotypes 144
Whole-lung densitometry versus visual assessment of emphysema 144
Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients. 143
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 143
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients 141
Asthma remission one, none and one-hundred thousand: the relevance of the patient’s view 140
“Adrenaline junkie”: a case report of repeated use of epinephrine 140
Classification of COPD patients by using standardised diagnostic procedures 140
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT 138
[Lymphangioleiomyomatosis. The computed tomographic aspects in an early case]. 136
Chest x-ray findings in different Phenotypes, GOLD stages and BODE scores of Chronic Obstructive Pulmonary Disease 134
EFFECT ON LUNG FUNCTION OF METHOTREXATE AND NON-STEROID ANTI-INFLAMMATORY DRUGS IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS 134
Omalizumab improves asthma-related quality of lifein allergic asthmatic patients 133
Classificazione diagnostica standardizzata dei pazienti con BPCO 132
Clinical utility of noninvasive methods in the evaluation of scleroderma lung in pediatric age 130
Effetti della terapia con metotrexate (MTX) e degli antiinfiammatori non steroidei sulla funzione polmonare e sulla capacità di diffusione in bambini affetti da artrite reumatoide giovanile 130
Determination of ai rway resistance (Raw) and pulmonary flow resistance (RL) during methacoline challenge in children 128
Modificazioni sequenziali cardio respiratorie in corso di danno lesionale sperimentale da acido oleico 128
In vitro validation and preliminary clinical application of a software for the computation of lung nodules volume in the Italung-CT trial 127
PULMONARY LYMPHANGIOLEIOMYOMATOSIS. A CASE REPORT AND REVIEW 126
Phenotypes of chronic obstructive pulmonary disease 126
Prediction by pulmonary function tests of HRCT lung density parameters in COPD 126
Cardiovascular comorbidities prevail in the early stages of COPD irrespective of predominant airway or emphysema phenotype 126
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? 126
Comparison of dose-response slopes obtained by simultaneous assessment of changes in FEV1 and transcutaneous oxygen partial pressure during methacholine challenges in asthmatic patients. 126
Clinical Identification of CT-Determined COPD Phenotypes 125
Expiratory quantitative HRCT parameters reflect better than inspiratory parameters disfunction in COPD. 125
What does phenotype mean in the field of COPD 125
Lung densitometry: Why, how and when 124
Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life 124
Malattie polmonari parenchimali diffuse 122
Omalizumab improves asthma-related quality of life in allergic asthmatic patient 122
PULMONARY FUNCTION IN CHILDREN AFFECTED BY JUVENILE SPONDYLOARTHROPATHY 120
Changes in the pattern of breathing and dyspnea sensation during methacholine-induced bronchoconstriction in asthmatic patiens 120
Valutazione dei parametri quantitativi derivati dalla tomografia computerizzata ad alta risoluzione (HRCT) in pazienti BPCO: confronto con i tests di funzionalità respiratoria 120
Densitometria vs visual score nella valutazione dell’enfisema polmonare con TC 120
High resolution and spirometric synchronization computerized tomography in chronic obstructive bronchopneumopathy 120
Severe asthma: One disease and multiple definitions 117
L’edema Polmonare 114
Valutazione densitometrica polmonare nella sclerosi sistemica. Riproducibilità e correlazioni clinico-funzionali 114
Impiego di un dispositivo di interruzione del flusso delle vie aeree per la misura delle resistenze respiratorie (RL) 113
Identification of a predominant clinical COPD phenotype in clinical practice 113
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 112
Spirometrically gated high-resolution CT findings in COPD: lung attenuation vs lung function and dyspnea severity. 109
High resolution computed tomography quantitative parameters in COPD. Comparison with pulmonary function tests 109
Italian real life experience of Omalizumab 107
Thin section CT and low dose volumetric CT densitometry of the lung in Systemic Sclerosis 107
Lung involvement in Juvenile dermatomyositis (JDM): Muscle strenght and pulmonary function tests in children with JDM 105
Mepolizumab Effectiveness and Allergic Status in Real Life 104
The Severe Asthma Network in Italy: Findings and Perspectives 99
Different cell compositions in induced sputum samples from patients with Systemic Sclerosis: relationship with antibodies and interstitial lung fibrosis 98
Defining the contribution of emphysema and chronic bronchitis in COPD patients 97
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 93
Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease: a comparison of 3 techniques. 93
Studio prospettico sulla funzionalità respiratoria e determinazione della forza muscolare in pazienti di età pediatrica affetti da dermatomiosite 93
Diagnostica per immagini della BPCO 93
Prediction of Pulmonary Function in COPD on the Basis of CT Measurements of Bronchial Wall Thickness 92
Clinical Phenotypes in patients with COPD 91
Interessamento polmonare in pazienti asintomatici con artrite reumatoide giovanile (ARG), HLAB27 positivi. Studio prospettico della funzionalità respiratoria 90
Whole-lung densitometry vs visual assessment of emphysema 89
Totale 15.201
Categoria #
all - tutte 49.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022759 28 112 23 55 20 12 14 55 22 20 129 269
2022/20232.033 216 235 71 147 179 390 282 104 295 27 57 30
2023/2024811 58 134 170 59 66 84 19 93 8 35 56 29
2024/20255.249 174 520 406 720 1.668 669 65 312 253 94 185 183
2025/20266.051 641 815 490 301 514 209 932 252 417 338 213 929
2026/202725 25 0 0 0 0 0 0 0 0 0 0 0
Totale 18.275